These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5564049)

  • 21. [Preliminary note on the hypourecemic effect of benzofuran (benziodarone)].
    Santamaría A; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1968 Apr; 12(6):377-80. PubMed ID: 5739949
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of amplivix in gout patients and nongouty arthrosic hyperuricemics].
    Doumerg C
    Rhumatologie; 1968 Oct; 20(8):285-8. PubMed ID: 5712175
    [No Abstract]   [Full Text] [Related]  

  • 23. [The hypo-uricemic action of oral benziodarone].
    Nivet M; Marcovici J; Compagnon P; Laruelle P
    Sem Hop; 1967 Jan; 43(2):135-8. PubMed ID: 4291740
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and biochemical study of a new uricosuric: benziodarone].
    Rapado A; Llamazares C
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):249-51. PubMed ID: 5736091
    [No Abstract]   [Full Text] [Related]  

  • 25. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R; Hueber EF
    Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract]   [Full Text] [Related]  

  • 26. [Benziodarone (Amplivix) in the treatment of hyperuricemia].
    Antila V; Elsilä M
    Duodecim; 1969; 85(7):428-30. PubMed ID: 5799173
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possible clinical use of benziodarone].
    Klabusay L; Raska P; Vykydal M; Pĕgrímová E; Duda V
    Fysiatr Revmatol Vestn; 1972 Dec; 50(6):352-7. PubMed ID: 4674180
    [No Abstract]   [Full Text] [Related]  

  • 28. [Uricosuric and anti-gout action of certain benzofuran derivatives].
    Delbarre F; Auscher C; Amor B
    Presse Med (1893); 1965 Nov; 73(48):2725-6. PubMed ID: 5842108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gout].
    Yoshimura T; Akaoka I
    Naika; 1971 Jun; 27(6):1286-90. PubMed ID: 5092040
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

  • 31. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP; Borner K
    Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thyrotoxicosis and benzidarone].
    Camus JP; Prier A; Kartun P; Mauguélis de Bourguesdon
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):148-50. PubMed ID: 4705339
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benziodarone in gout therapy].
    Ryckewaert A; Kuntz D
    Therapeutique; 1970 Dec; 46(10):989-91. PubMed ID: 5511935
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hyperuricemia in gout and renal insufficiency with benziodarone].
    Richet G; Cottet J; Amiel C; Leroux-Robert C; Podevin R
    Presse Med (1893); 1966 May; 74(24):1247-9. PubMed ID: 5936081
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Benzodiarone in the therapy of gout].
    Chériè Lignière G; Solazzi F
    Reumatismo; 1968; 20(1):53-62. PubMed ID: 5708869
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies with a new hypo-urecemic product].
    Vanslype J
    J Belge Rhumatol Med Phys; 1967; 22(2):61-8. PubMed ID: 6045653
    [No Abstract]   [Full Text] [Related]  

  • 38. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E; Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic effectiveness of the combination allopurinol-benziodarone in the treatment of hyperuricemia].
    Pecora P; Suraci C; Dessì R; De Maria S; Assisi A
    Clin Ter; 1982 Mar; 100(5):463-76. PubMed ID: 6982797
    [No Abstract]   [Full Text] [Related]  

  • 40. [Benziodarone in coronary insufficiency therapy, double blind test].
    Oter Rodríguez R; Vilalta Bernet C; Balauguer Vintro I; Domínguez De Rozas J
    Rev Clin Esp; 1968 Mar; 108(5):384-8. PubMed ID: 4878005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.